4EGC image
Deposition Date 2012-03-30
Release Date 2013-02-27
Last Version Date 2024-02-28
Entry Detail
PDB ID:
4EGC
Title:
Crystal Structure of MBP-fused Human Six1 Bound to Human Eya2 Eya Domain
Biological Source:
Source Organism:
Escherichia coli (Taxon ID: 562)
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.99 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 21 21 2
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Maltose-binding periplasmic protein, Homeobox protein SIX1 chimera
Gene (Uniprot):malE, SIX1
Mutagens:E172A,N173A,E359A,K362A,D363A
Chain IDs:A
Chain Length:559
Number of Molecules:1
Biological Source:Escherichia coli, Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Eyes absent homolog 2
Gene (Uniprot):EYA2
Chain IDs:B
Chain Length:294
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Peptide-like Molecules
PRD_900001
Primary Citation
Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome.
Nat.Struct.Mol.Biol. 20 447 453 (2013)
PMID: 23435380 DOI: 10.1038/nsmb.2505

Abstact

SIX1 interacts with EYA to form a bipartite transcription factor essential for mammalian development. Loss of function of this complex causes branchio-oto-renal (BOR) syndrome, whereas re-expression of SIX1 or EYA promotes metastasis. Here we describe the 2.0-Å structure of SIX1 bound to EYA2, which suggests a new DNA-binding mechanism for SIX1 and provides a rationale for the effect of BOR syndrome mutations. The structure also reveals that SIX1 uses predominantly a single helix to interact with EYA. Substitution of a single amino acid in this helix is sufficient to disrupt SIX1-EYA interaction, SIX1-mediated epithelial-mesenchymal transition and metastasis in mouse models. Given that SIX1 and EYA are overexpressed in many tumor types, our data indicate that targeting the SIX1-EYA complex may be a potent approach to inhibit tumor progression in multiple cancer types.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback